Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Löck, Steffen  [Clear All Filters]
2022
Löck S, Linge A, Lohaus F, Ebert N, Gudziol V, Nowak A, Tinhofer I, Kalinauskaite G, Guberina M, Stuschke M, et al. Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC - hypothesis generation on a multicentre cohort of the DKTK-ROG. Radiother Oncol. 2022.
Schniewind I, Hadiwikarta WWijaya, Grajek J, Poleszczuk J, Richter S, Peitzsch M, Müller J, Klusa D, Beyreuther E, Löck S, et al. Cellular plasticity upon proton irradiation determines tumor cell radiosensitivity. Cell Rep. 2022;38(8):110422.
2021
Ciecior W, Ebert N, Borgeaud N, Thames HD, Baumann M, Krause M, Löck S. Sample-size calculation for preclinical dose-response experiments using heterogeneous tumour models. Radiother Oncol. 2021.
Kummer B, Löck S, Gurtner K, Hermann N, Yaromina A, Eicheler W, Baumann M, Krause M, Jentsch C. Value of functional in-vivo endpoints in preclinical radiation research. Radiother Oncol. 2021.
2020
Schmidt S, Linge A, Großer M, Lohaus F, Gudziol V, Nowak A, Tinhofer I, Budach V, Sak A, Stuschke M, et al. Comparison of GeneChip, nCounter and real-time polymerase chain reaction based gene expressions predicting loco-regional tumour control after primary and postoperative radiochemotherapy in head and neck squamous cell carcinoma. J Mol Diagn. 2020.
2018
Cordes N, Ney M, Beleites T, Aust D, Baretton G, Thames H, Baumann M, Krause M, Löck S, Appold S. Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapy. PLoS One. 2018;13(12):e0209479.